1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global 5'Nucleotidase Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Single Dose 1.2.3 Combination Therapy 1.3 Market by Application 1.3.1 Global 5'Nucleotidase Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global 5'Nucleotidase Market Perspective (2016-2027) 2.2 5'Nucleotidase Growth Trends by Regions 2.2.1 5'Nucleotidase Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 5'Nucleotidase Historic Market Share by Regions (2016-2021) 2.2.3 5'Nucleotidase Forecasted Market Size by Regions (2022-2027) 2.3 5'Nucleotidase Industry Dynamic 2.3.1 5'Nucleotidase Market Trends 2.3.2 5'Nucleotidase Market Drivers 2.3.3 5'Nucleotidase Market Challenges 2.3.4 5'Nucleotidase Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top 5'Nucleotidase Players by Revenue 3.1.1 Global Top 5'Nucleotidase Players by Revenue (2016-2021) 3.1.2 Global 5'Nucleotidase Revenue Market Share by Players (2016-2021) 3.2 Global 5'Nucleotidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by 5'Nucleotidase Revenue 3.4 Global 5'Nucleotidase Market Concentration Ratio 3.4.1 Global 5'Nucleotidase Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by 5'Nucleotidase Revenue in 2020 3.5 5'Nucleotidase Key Players Head office and Area Served 3.6 Key Players 5'Nucleotidase Product Solution and Service 3.7 Date of Enter into 5'Nucleotidase Market 3.8 Mergers & Acquisitions, Expansion Plans 4 5'Nucleotidase Breakdown Data by Type 4.1 Global 5'Nucleotidase Historic Market Size by Type (2016-2021) 4.2 Global 5'Nucleotidase Forecasted Market Size by Type (2022-2027) 5 5'Nucleotidase Breakdown Data by Application 5.1 Global 5'Nucleotidase Historic Market Size by Application (2016-2021) 5.2 Global 5'Nucleotidase Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America 5'Nucleotidase Market Size (2016-2027) 6.2 North America 5'Nucleotidase Market Size by Type 6.2.1 North America 5'Nucleotidase Market Size by Type (2016-2021) 6.2.2 North America 5'Nucleotidase Market Size by Type (2022-2027) 6.2.3 North America 5'Nucleotidase Market Size by Type (2016-2027) 6.3 North America 5'Nucleotidase Market Size by Application 6.3.1 North America 5'Nucleotidase Market Size by Application (2016-2021) 6.3.2 North America 5'Nucleotidase Market Size by Application (2022-2027) 6.3.3 North America 5'Nucleotidase Market Size by Application (2016-2027) 6.4 North America 5'Nucleotidase Market Size by Country 6.4.1 North America 5'Nucleotidase Market Size by Country (2016-2021) 6.4.2 North America 5'Nucleotidase Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe 5'Nucleotidase Market Size (2016-2027) 7.2 Europe 5'Nucleotidase Market Size by Type 7.2.1 Europe 5'Nucleotidase Market Size by Type (2016-2021) 7.2.2 Europe 5'Nucleotidase Market Size by Type (2022-2027) 7.2.3 Europe 5'Nucleotidase Market Size by Type (2016-2027) 7.3 Europe 5'Nucleotidase Market Size by Application 7.3.1 Europe 5'Nucleotidase Market Size by Application (2016-2021) 7.3.2 Europe 5'Nucleotidase Market Size by Application (2022-2027) 7.3.3 Europe 5'Nucleotidase Market Size by Application (2016-2027) 7.4 Europe 5'Nucleotidase Market Size by Country 7.4.1 Europe 5'Nucleotidase Market Size by Country (2016-2021) 7.4.2 Europe 5'Nucleotidase Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific 5'Nucleotidase Market Size (2016-2027) 8.2 Asia-Pacific 5'Nucleotidase Market Size by Type 8.2.1 Asia-Pacific 5'Nucleotidase Market Size by Type (2016-2021) 8.2.2 Asia-Pacific 5'Nucleotidase Market Size by Type (2022-2027) 8.2.3 Asia-Pacific 5'Nucleotidase Market Size by Type (2016-2027) 8.3 Asia-Pacific 5'Nucleotidase Market Size by Application 8.3.1 Asia-Pacific 5'Nucleotidase Market Size by Application (2016-2021) 8.3.2 Asia-Pacific 5'Nucleotidase Market Size by Application (2022-2027) 8.3.3 Asia-Pacific 5'Nucleotidase Market Size by Application (2016-2027) 8.4 Asia-Pacific 5'Nucleotidase Market Size by Region 8.4.1 Asia-Pacific 5'Nucleotidase Market Size by Region (2016-2021) 8.4.2 Asia-Pacific 5'Nucleotidase Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America 5'Nucleotidase Market Size (2016-2027) 9.2 Latin America 5'Nucleotidase Market Size by Type 9.2.1 Latin America 5'Nucleotidase Market Size by Type (2016-2021) 9.2.2 Latin America 5'Nucleotidase Market Size by Type (2022-2027) 9.2.3 Latin America 5'Nucleotidase Market Size by Type (2016-2027) 9.3 Latin America 5'Nucleotidase Market Size by Application 9.3.1 Latin America 5'Nucleotidase Market Size by Application (2016-2021) 9.3.2 Latin America 5'Nucleotidase Market Size by Application (2022-2027) 9.3.3 Latin America 5'Nucleotidase Market Size by Application (2016-2027) 9.4 Latin America 5'Nucleotidase Market Size by Country 9.4.1 Latin America 5'Nucleotidase Market Size by Country (2016-2021) 9.4.2 Latin America 5'Nucleotidase Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa 5'Nucleotidase Market Size (2016-2027) 10.2 Middle East & Africa 5'Nucleotidase Market Size by Type 10.2.1 Middle East & Africa 5'Nucleotidase Market Size by Type (2016-2021) 10.2.2 Middle East & Africa 5'Nucleotidase Market Size by Type (2022-2027) 10.2.3 Middle East & Africa 5'Nucleotidase Market Size by Type (2016-2027) 10.3 Middle East & Africa 5'Nucleotidase Market Size by Application 10.3.1 Middle East & Africa 5'Nucleotidase Market Size by Application (2016-2021) 10.3.2 Middle East & Africa 5'Nucleotidase Market Size by Application (2022-2027) 10.3.3 Middle East & Africa 5'Nucleotidase Market Size by Application (2016-2027) 10.4 Middle East & Africa 5'Nucleotidase Market Size by Country 10.4.1 Middle East & Africa 5'Nucleotidase Market Size by Country (2016-2021) 10.4.2 Middle East & Africa 5'Nucleotidase Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bristol-Myers Squibb 11.1.1 Bristol-Myers Squibb Company Details 11.1.2 Bristol-Myers Squibb Business Overview 11.1.3 Bristol-Myers Squibb 5'Nucleotidase Introduction 11.1.4 Bristol-Myers Squibb Revenue in 5'Nucleotidase Business (2016-2021) 11.1.5 Bristol-Myers Squibb Recent Development 11.2 Corvus Pharmaceuticals 11.2.1 Corvus Pharmaceuticals Company Details 11.2.2 Corvus Pharmaceuticals Business Overview 11.2.3 Corvus Pharmaceuticals 5'Nucleotidase Introduction 11.2.4 Corvus Pharmaceuticals Revenue in 5'Nucleotidase Business (2016-2021) 11.2.5 Corvus Pharmaceuticals Recent Development 11.3 Innate Pharma 11.3.1 Innate Pharma Company Details 11.3.2 Innate Pharma Business Overview 11.3.3 Innate Pharma 5'Nucleotidase Introduction 11.3.4 Innate Pharma Revenue in 5'Nucleotidase Business (2016-2021) 11.3.5 Innate Pharma Recent Development 11.4 MedImmune 11.4.1 MedImmune Company Details 11.4.2 MedImmune Business Overview 11.4.3 MedImmune 5'Nucleotidase Introduction 11.4.4 MedImmune Revenue in 5'Nucleotidase Business (2016-2021) 11.4.5 MedImmune Recent Development 11.5 Surface Oncology 11.5.1 Surface Oncology Company Details 11.5.2 Surface Oncology Business Overview 11.5.3 Surface Oncology 5'Nucleotidase Introduction 11.5.4 Surface Oncology Revenue in 5'Nucleotidase Business (2016-2021) 11.5.5 Surface Oncology Recent Development 11.6 Vitae Pharmaceuticals 11.6.1 Vitae Pharmaceuticals Company Details 11.6.2 Vitae Pharmaceuticals Business Overview 11.6.3 Vitae Pharmaceuticals 5'Nucleotidase Introduction 11.6.4 Vitae Pharmaceuticals Revenue in 5'Nucleotidase Business (2016-2021) 11.6.5 Vitae Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global 5'Nucleotidase Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Single Dose Table 3. Key Players of Combination Therapy Table 4. Global 5'Nucleotidase Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global 5'Nucleotidase Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global 5'Nucleotidase Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global 5'Nucleotidase Market Share by Regions (2016-2021) Table 8. Global 5'Nucleotidase Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global 5'Nucleotidase Market Share by Regions (2022-2027) Table 10. 5'Nucleotidase Market Trends Table 11. 5'Nucleotidase Market Drivers Table 12. 5'Nucleotidase Market Challenges Table 13. 5'Nucleotidase Market Restraints Table 14. Global 5'Nucleotidase Revenue by Players (2016-2021) & (US$ Million) Table 15. Global 5'Nucleotidase Market Share by Players (2016-2021) Table 16. Global Top 5'Nucleotidase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5'Nucleotidase as of 2020) Table 17. Ranking of Global Top 5'Nucleotidase Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by 5'Nucleotidase Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players 5'Nucleotidase Product Solution and Service Table 21. Date of Enter into 5'Nucleotidase Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million) Table 24. Global 5'Nucleotidase Revenue Market Share by Type (2016-2021) Table 25. Global 5'Nucleotidase Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global 5'Nucleotidase Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global 5'Nucleotidase Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global 5'Nucleotidase Revenue Market Share by Application (2016-2021) Table 29. Global 5'Nucleotidase Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global 5'Nucleotidase Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million) Table 32. North America 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million) Table 33. North America 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million) Table 34. North America 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million) Table 35. North America 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million) Table 36. North America 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million) Table 38. Europe 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million) Table 40. Europe 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific 5'Nucleotidase Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific 5'Nucleotidase Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million) Table 61. Bristol-Myers Squibb Company Details Table 62. Bristol-Myers Squibb Business Overview Table 63. Bristol-Myers Squibb 5'Nucleotidase Product Table 64. Bristol-Myers Squibb Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million) Table 65. Bristol-Myers Squibb Recent Development Table 66. Corvus Pharmaceuticals Company Details Table 67. Corvus Pharmaceuticals Business Overview Table 68. Corvus Pharmaceuticals 5'Nucleotidase Product Table 69. Corvus Pharmaceuticals Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million) Table 70. Corvus Pharmaceuticals Recent Development Table 71. Innate Pharma Company Details Table 72. Innate Pharma Business Overview Table 73. Innate Pharma 5'Nucleotidase Product Table 74. Innate Pharma Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million) Table 75. Innate Pharma Recent Development Table 76. MedImmune Company Details Table 77. MedImmune Business Overview Table 78. MedImmune 5'Nucleotidase Product Table 79. MedImmune Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million) Table 80. MedImmune Recent Development Table 81. Surface Oncology Company Details Table 82. Surface Oncology Business Overview Table 83. Surface Oncology 5'Nucleotidase Product Table 84. Surface Oncology Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million) Table 85. Surface Oncology Recent Development Table 86. Vitae Pharmaceuticals Company Details Table 87. Vitae Pharmaceuticals Business Overview Table 88. Vitae Pharmaceuticals 5'Nucleotidase Product Table 89. Vitae Pharmaceuticals Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million) Table 90. Vitae Pharmaceuticals Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global 5'Nucleotidase Market Share by Type: 2020 VS 2027 Figure 2. Single Dose Features Figure 3. Combination Therapy Features Figure 4. Global 5'Nucleotidase Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Ambulatory Surgical Centers Case Studies Figure 7. Others Case Studies Figure 8. 5'Nucleotidase Report Years Considered Figure 9. Global 5'Nucleotidase Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global 5'Nucleotidase Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global 5'Nucleotidase Market Share by Regions: 2020 VS 2027 Figure 12. Global 5'Nucleotidase Market Share by Regions (2022-2027) Figure 13. Global 5'Nucleotidase Market Share by Players in 2020 Figure 14. Global Top 5'Nucleotidase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5'Nucleotidase as of 2020 Figure 15. The Top 10 and 5 Players Market Share by 5'Nucleotidase Revenue in 2020 Figure 16. Global 5'Nucleotidase Revenue Market Share by Type (2016-2021) Figure 17. Global 5'Nucleotidase Revenue Market Share by Type (2022-2027) Figure 18. North America 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America 5'Nucleotidase Market Share by Type (2016-2027) Figure 20. North America 5'Nucleotidase Market Share by Application (2016-2027) Figure 21. North America 5'Nucleotidase Market Share by Country (2016-2027) Figure 22. United States 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe 5'Nucleotidase Market Share by Type (2016-2027) Figure 26. Europe 5'Nucleotidase Market Share by Application (2016-2027) Figure 27. Europe 5'Nucleotidase Market Share by Country (2016-2027) Figure 28. Germany 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific 5'Nucleotidase Market Share by Type (2016-2027) Figure 36. Asia-Pacific 5'Nucleotidase Market Share by Application (2016-2027) Figure 37. Asia-Pacific 5'Nucleotidase Market Share by Region (2016-2027) Figure 38. China 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America 5'Nucleotidase Market Share by Type (2016-2027) Figure 46. Latin America 5'Nucleotidase Market Share by Application (2016-2027) Figure 47. Latin America 5'Nucleotidase Market Share by Country (2016-2027) Figure 48. Mexico 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa 5'Nucleotidase Market Share by Type (2016-2027) Figure 52. Middle East & Africa 5'Nucleotidase Market Share by Application (2016-2027) Figure 53. Middle East & Africa 5'Nucleotidase Market Share by Country (2016-2027) Figure 54. Turkey 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Bristol-Myers Squibb Revenue Growth Rate in 5'Nucleotidase Business (2016-2021) Figure 58. Corvus Pharmaceuticals Revenue Growth Rate in 5'Nucleotidase Business (2016-2021) Figure 59. Innate Pharma Revenue Growth Rate in 5'Nucleotidase Business (2016-2021) Figure 60. MedImmune Revenue Growth Rate in 5'Nucleotidase Business (2016-2021) Figure 61. Surface Oncology Revenue Growth Rate in 5'Nucleotidase Business (2016-2021) Figure 62. Vitae Pharmaceuticals Revenue Growth Rate in 5'Nucleotidase Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Bristol-Myers Squibb Corvus Pharmaceuticals Innate Pharma MedImmune Surface Oncology Vitae Pharmaceuticals